Hualan Biological Engineering Inc. (SHE:002007)
China flag China · Delayed Price · Currency is CNY
11.73
+0.05 (0.43%)
Nov 17, 2026, 3:04 PM CST

SHE:002007 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
586.58940.41,0881,4821,0761,299
Depreciation & Amortization
274.45274.45261.03259.59272.82196.45
Other Amortization
7.17.111.3114.214.7710.04
Loss (Gain) From Sale of Assets
-2.89-2.89-0.08-44.44-47.67-0.42
Asset Writedown & Restructuring Costs
3.533.535.719.711.193.23
Loss (Gain) From Sale of Investments
-77.67-77.67-170.46-209.59-144.05-100.22
Provision & Write-off of Bad Debts
34.0634.06-5.5913.9232.8311.29
Other Operating Activities
403.64127.8154.97384.37358.97309.88
Change in Accounts Receivable
-423.1-423.1840.46-302.66-538.11162.97
Change in Inventory
-317.32-317.32-416.88-316.45-245.23-317.36
Change in Accounts Payable
333.3333.3-723.837.97190.01-137.32
Change in Other Net Operating Assets
-28.16-28.1611.1534.826.364.14
Operating Cash Flow
799.98877.961,0591,346957.311,432
Operating Cash Flow Growth
-23.83%-17.12%-21.29%40.59%-33.17%8.09%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-181.35-197.31-255.43-753.41-393.95-811.35
Sale of Property, Plant & Equipment
3.432.690.89204.1150.320.91
Divestitures
1.57-1.55---
Investment in Securities
644.98464.89208.13-536.92-2,175-1,075
Other Investing Activities
185.26264.01134.9387.9468.89126.6
Investing Cash Flow
653.89534.2890.08-998.28-2,450-1,759

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-724.94596.47---
Long-Term Debt Issued
---7001,1001,300
Total Debt Issued
987.89724.94596.477001,1001,300
Short-Term Debt Repaid
--1,179-700---
Long-Term Debt Repaid
---0.95-600.38-1,001-700
Lease Payments
---0.95-0.38-0.76-
Total Debt Repaid
-837-1,179-700.95-600.38-1,001-700
Net Debt Issued (Repaid)
150.89-454.44-104.4899.6299.24600
Issuance of Common Stock
--16.2848.072,255-
Repurchase of Common Stock
-14.02-14.02-106.79---
Common Dividends Paid
-1,935-1,361-467.83-563.64-399.47-564.11
Other Financing Activities
-266.2-167.12-117.62-39-36.57-
Financing Cash Flow
-2,064-1,997-780.43-454.961,91835.89

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.260.14-0.050.060.05-0.03
Net Cash Flow
-610.27-584.68368.94-107.33425.29-290.45

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
618.63680.65803.92592.43563.36621.15
Free Cash Flow Growth
-43.96%-15.33%35.70%5.16%-9.30%-11.75%
Free Cash Flow Margin
16.29%14.81%18.36%11.09%12.47%14.00%
Free Cash Flow Per Share
0.340.370.440.330.310.34
Levered Free Cash Flow
-718.54408.591,422276.91-258.06252
Unlevered Free Cash Flow
-715.44414.991,431285.14-239.15265.58
Free Cash Flow After Leases
618.63680.65802.97592.05562.6621.15

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
412.6395.87494.25503.9457.29564.96
Change in Working Capital
-428.82-428.82-285.4-563.51-607.8-296.66